NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography

RecruitingNA

Sponsor: Norwegian University of Science and Technology

Conditions: Breast Neoplasm Malignant Primary

Interventions: Comprehensive echocardiographic follow-up, Simplified echocardiographic follow-up

Countries: Norway

TRUST-ACE will compare a simplified echocardiographic protocol focusing on ventricular function with the guideline recommended comprehensive echocardiographic examination using a randomised design in follow-up of breast-cancer patients with respect to identification of cancer treatment related cardiac dysfunction (CTRCD). Secondly, the study will evaluate whether novel tools used to improve standardization of recordings as well as automated measurements of central measurements, e.g. ejection fraction (EF) and global longitudinal strain (GLS) can improve the precision of echocardiography in daily clinical practice.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Breast cancer and referral for follow-up to identify potential CTRCD

Exclusion Criteria:

* Not willing or able to consent

Locations (1)

Trondheim, Norway